Aims & Scope
npj Vaccines is a multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines, including:
- discovery and basic science
- nonclinical development of vaccines
- biodefense vaccine
- AIDS vaccine
- vaccine formulation
- vaccine adjuvants and conjugate vaccines
- cancer/oncology vaccines
- clinical evaluation of vaccines
- vaccine safety
- regulatory science
- conventional and non-conventional vaccines
- live, attenuated vaccines
- inactivated vaccines
- subunit vaccines
- toxoid vaccines
- DNA vaccines
- recombinant vector vaccines.
Each original research article will include an Editorial Summary that will summarize the key issues being addressed within the article with the goal of keeping the readership informed of advances in the field of vaccinology.
Given the public health importance of vaccines, in addition to publishing high-quality original research, npj Vaccines also publishes commentaries, News and Views (or a similar format), research highlights, editorials, and correspondence from readers, to provide state-of-the-art information for those interested in vaccines.
Article and journal metrics
Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.
The 2017 journal metrics for npj Vaccines are as follows:
|2-year Impact Factor||5-year Impact Factor||Immediacy index||Eigenfactor® score||Article Influence Score|
For a further description of these metrics and a summary of the metrics for all Nature journals, please visit our journal metrics page. More information underlying our approach to journal metrics may be found here.
Abstracting and Indexing
npj Vaccines is listed within leading abstracting and indexing services including Scopus, PubMed Central, PubMed, Science Citation Index Expanded (SCIE), Biological Abstracts, BIOSIS Previews and Directory of Open Access Journals (DOAJ).